US 4522811A
· Eppestein et al.
· 1985
[cited by applicant]
US 6455298B1
· Groner et al.
· 2002
[cited by applicant]
US 6544788B2
· Singh
· 2003
[cited by applicant]
US 7354576B2
· Kakkis
· 2008
[cited by applicant]
US 7767446B2
· Robbins et al.
· 2010
[cited by applicant]
US 8617879B2
· Yu et al.
· 2013
[cited by applicant]
US 9909101B2
· Yang et al.
· 2018
[cited by applicant]
US 20030096366A1
· Knudsen
· 2003
[cited by applicant]
US 20050019914A1
· Staerk et al.
· 2005
[cited by applicant]
US 20050186669A1
· Ho et al.
· 2005
[cited by applicant]
US 20080199958A1
· Hui
· 2008
[cited by applicant]
US 20080206819A1
· Tsao et al.
· 2008
[cited by applicant]
US 20090042253A1
· Hiller et al.
· 2009
[cited by applicant]
US 20090233334A1
· Hildinger et al.
· 2009
[cited by applicant]
US 20100076380A1
· Hui
· 2010
[cited by applicant]
US 20110020929A1
· Schober et al.
· 2011
[cited by applicant]
US 20110212493A1
· Hirschel et al.
· 2011
[cited by applicant]
US 20120101442A1
· Legaspi et al.
· 2012
[cited by applicant]
US 20130260419A1
· Ransohoff et al.
· 2013
[cited by applicant]
US 20140154726A1
· Yang et al.
· 2014
[cited by applicant]
US 20150158907A1
· Zhou et al.
· 2015
[cited by applicant]
US 20150203532A1
· Godawat et al.
· 2015
[cited by applicant]
US 20200080063A1
· Yang et al.
· 2020
[cited by applicant]
US 20200255798A1
· Yang et al.
· 2020
[cited by applicant]
US 20200377850A1
· Bruninghaus et al.
· 2020
[cited by applicant]
CA 2838695
· 2013
[cited by applicant]
CA 2901940
· 2014
[cited by applicant]
CN 1373799
· 2002
[cited by applicant]
CN 1564863
· 2005
[cited by applicant]
CN 101875917
· 2010
[cited by applicant]
CN 201933090
· 2010
[cited by applicant]
CN 104450597
· 2015
[cited by applicant]
CN 104480897
· 2015
[cited by applicant]
CN 106795495
· 2017
[cited by applicant]
EP 1451290
· 2004
[cited by applicant]
EP 1508576
· 2005
[cited by applicant]
EP 1395647
· 2006
[cited by applicant]
EP 2020433
· 2009
[cited by applicant]
EP 2163640
· 2010
[cited by applicant]
EP 2958989
· 2015
[cited by applicant]
EP 3152299
· 2019
[cited by applicant]
JP 2005502306
· 2005
[cited by applicant]
JP 2005509173
· 2005
[cited by applicant]
JP 2005509406
· 2005
[cited by applicant]
JP 2008511329
· 2008
[cited by applicant]
JP 2008513013A
· 2008
[cited by applicant]
JP 2010519917
· 2010
[cited by applicant]
JP 2010525789
· 2010
[cited by applicant]
JP 2011072322
· 2011
[cited by applicant]
JP 2012531930
· 2012
[cited by applicant]
JP 2013520975
· 2013
[cited by applicant]
JP 2013544524
· 2013
[cited by applicant]
JP 2017500017
· 2017
[cited by applicant]
RU 2058992
· 1996
[cited by applicant]
RU 2215748
· 2003
[cited by applicant]
RU 2380412
· 2010
[cited by applicant]
RU 2016152238
· 2018
[cited by applicant]
WO WO2001018175
· 2001
[cited by applicant]
WO WO2002050251
· 2002
[cited by applicant]
WO WO2003029442
· 2003
[cited by applicant]
WO WO2003039459
· 2003
[cited by applicant]
WO WO2003042233
· 2003
[cited by applicant]
WO WO2003033935
· 2006
[cited by applicant]
WO WO2006033935
· 2006
[cited by applicant]
WO WO2006039588
· 2006
[cited by applicant]
WO WO2006138143
· 2006
[cited by applicant]
WO WO2008073620
· 2008
[cited by applicant]
WO WO2008085962
· 2008
[cited by applicant]
WO WO2008106515
· 2008
[cited by applicant]
WO WO2008127087
· 2008
[cited by applicant]
WO WO2009023562
· 2009
[cited by applicant]
WO WO2009034186
· 2009
[cited by applicant]
WO WO2011005773
· 2011
[cited by applicant]
WO WO2012098055
· 2012
[cited by applicant]
WO WO2012078677
· 2012
[cited by applicant]
WO WO2012152945
· 2012
[cited by applicant]
WO WO2013006479
· 2013
[cited by applicant]
WO WO2013090820
· 2013
[cited by applicant]
WO WO2013113449
· 2013
[cited by applicant]
WO WO2013116449
· 2013
[cited by applicant]
WO WO2013151616
· 2013
[cited by applicant]
WO WO2014055519
· 2014
[cited by applicant]
WO WO2014066519
· 2014
[cited by applicant]
WO WO2012127523
· 2014
[cited by applicant]
WO WO2014130864
· 2014
[cited by applicant]
WO WO2014130872
· 2014
[cited by applicant]
WO WO2014137903
· 2014
[cited by applicant]
WO WO2014143691
· 2014
[cited by applicant]
WO WO2015039115
· 2015
[cited by applicant]
WO WO2015095809
· 2015
[cited by applicant]
WO WO2015109146
· 2015
[cited by applicant]
WO WO2015109151
· 2015
[cited by applicant]
WO WO2015188009
· 2015
[cited by applicant]
WO WO2015188106
· 2015
[cited by applicant]
WO WO2015191462
· 2015
[cited by applicant]
WO WO2016106192
· 2016
[cited by applicant]
U.S. Appl. No. 14/061,657, filed Oct. 23, 2013, Yang et al.
[cited by applicant]
U.S. Appl. No. 14/195,481, filed Mar. 3, 2014, Konstantinov et al.
[cited by applicant]
U.S. Appl. No. 14/212,607, filed Mar. 14, 2014, Jin et al.
[cited by applicant]
U.S. Appl. No. 14/769,772, filed Aug. 21, 2015, Yang et al.
[cited by applicant]
U.S. Appl. No. 14/769,783, filed Aug. 21, 2015, Jianguo et al.
[cited by applicant]
U.S. Appl. No. 14/976,486, filed Dec. 21, 2016, Bae et al.
[cited by applicant]
U.S. Appl. No. 62/009,058, filed Jun. 6, 2014, Villiger-Oberbek et al.
[cited by applicant]
U.S. Appl. No. 62/009,553, filed Jun. 9, 2014, Bruninghaus et al.
[cited by applicant]
U.S. Appl. No. 62/095,734, filed Dec. 22, 2014, Bae et al.
[cited by applicant]
Abu-Absi et al., “Cell Culture Process Operations for Recombinant Protein Production,” Adv Biochem Eng Biotechnol, Oct. 24, 2013, 139: 35-68.
[cited by applicant]
Abu-Absi, “Mammalian Cell Cultures for Biologics,” Advances in Biochemical Engineering/Biotechnology, Oct. 24, 2013, Confirmation about date of publication, 25 pages.
[cited by applicant]
Adams et al., “Increasing efficiency in protein supply and cell production by combining single-use bioreactor technology and perfusion,” BioPharm International, May 2, 2011, pp. s4-s11.
[cited by applicant]
Banik et al., “An investigation of cell density effects on hybridoma metabolism in a homogeneous perfusion reactor”, Bioprocess Engineering, 1994, vol. 11: 229-237.
[cited by applicant]
Barrett et al., “Microwell engineering characterization for mammalian cell culture process development,” Biotechnol Bioeng., Feb. 1, 2010, 105(2):260-275.
[cited by applicant]
Birch et al., “Antibody production”, Advanced Drug Delivery, 2006, vol. 58, pp. 671-685.
[cited by applicant]
Boedeker, “Recombinant factor VIII (Kogenate®) for the treatment of hemophilia A: The first and only world-wide licensed recombinant protein produced in high-throughput perfusion culture,” Modern Biopharmaceuticals: Rec…
[cited by applicant]
Bonham-Carter et al., “A brief history of perfusion biomanufacturing: How high-concentration cultures will characterize the factory of the future,” Bioprocess International, Oct. 2011, 9(9):24-30.
[cited by applicant]
Castilho, “Continuous Animal Cell Perfusion Processes: The First Step Toward Integrated Continuous Biomanufacturing,” Continuous Processing in Pharmaceutical Manufacturing, Dec. 5, 2014, Chapter 6.
[cited by applicant]
Castilho, “Continuous Animal Cell Perfusion Processes: The First Step Toward Integrated Continuous Biomanufacturing,” Continuous Processing in Pharmaceutical Manufacturing, Dec. 5, 2014, Confirmation about date of publi…
[cited by applicant]
Chaturvedi et al., “Comparison of the behavior of CHO cells during cultivation in 24-square deep well microplates and conventional shake flask systems,” Biotechnology Reports., 2014, 1: 22-26.
[cited by applicant]
Chinese Search Report in Patent Application No. 201580042017.6, dated Aug. 2, 2019, 2 pages (English Translation Only).
[cited by applicant]
Chmiel, “Kulitivierung von Saugerzellen”, BioProzesstechnik, 2011, Chapter 11, 57 pages (with English summary).
[cited by applicant]
Chotteau, “Perfusion Processes”, Animal Cell Culture, 2015, Chapter 13, 38 pages.
[cited by applicant]
Chotteau, “Perfusion Processes”, Confirmation of Publication, Animal Cell Culture, 2015, Chapter 13, 38 pages.
[cited by applicant]
Chu et al., “Overview on Large-Scale Animal Cell Culture Technology,” Process in Veterinary Medicine, Feb. 20, 2018, 39(2):119-123 (with English Abstract).
[cited by applicant]
Clincke et al., “Very high density of Chinese hamster ovary cells in perfusion by alternating tangential flow or tangential flow filtration in Wave Bioreactor TM, Part II: Applications for antibody production and Cryopr…
[cited by applicant]
Clincke et al., “Very high density of CHO cells in perfusion by ATF or TFF in Wave bioreactor. Part I: Effect of the cell density on the process,” Biotechnol. Prog., May 2013, 29(3):754-767.
[cited by applicant]
coleparmer.com [online], “Corning 4500-1L ProCulture Spinner Flask, 1000 mL; 1/Pk from Cole-Parmer”, 2018, retrieved on Mar. 12, 2018, retrieved from URL: <https://www.coleparmer.com/i/mn/0183706>, 2 pages.
[cited by applicant]
Communication in European Patent Application No. 13786587.9, dated Feb. 20, 2017, 6 pages.
[cited by applicant]
Communication in European Patent Application No. 13786587.9, dated Mar. 15, 2016, 5 pages.
[cited by applicant]
Communication in European Patent Application No. 13786587.9, dated Nov. 28, 2017, 6 pages.
[cited by applicant]
Communication in European Patent Application No. 13786587.9, dated Sep. 27, 2016, 11 pages.
[cited by applicant]
Communication in European Patent Application No. 13786587.9, dated Sep. 27, 2018, 6 pages.
[cited by applicant]
Communication in European Patent Application No. 14079829.7, dated Aug. 30, 2017, 3 pages.
[cited by applicant]
Communication in European Patent Application No. 14709106.0, dated Dec. 6, 2018, 8 pages.
[cited by applicant]
Communication in European Patent Application No. 14709106.0, dated Jul. 1, 2019, 4 pages.
[cited by applicant]
Communication in European Patent Application No. 14709106.0, dated Mar. 30, 2020, 7 pages.
[cited by applicant]
Communication in European Patent Application No. 14709106.0, dated Oct. 17, 2017, 5 pages.
[cited by applicant]
Communication in European Patent Application No. 14709829.7, dated Aug. 31, 2017, 5 pages.
[cited by applicant]
Communication in European Patent Application No. 14709829.7, dated Jun. 27, 2016, 5 pages.
[cited by applicant]
Communication in European Patent Application No. 15730933.7, dated Oct. 23, 2017, 2 pages.
[cited by applicant]
Communication in European Patent Application No. 15731177.0, dated Mar. 23, 2020, 10 pages.
[cited by applicant]
Communication in European Patent Application No. 18205923.8, dated Apr. 23, 2020, 6 pages.
[cited by applicant]
Corning-24, “Corning Costar Ultra-low attachment multiwell plates, Sigma-Aldrich,” Catalog Webpage, Retrieved Jan. 10, 2018, Retrieved from: URL<https://www.sigmaaldrich.com/catalog/product/sigma/cls3473?lang=en®ion=…
[cited by applicant]
Costa et al., “The impact of microcarrier culture optimization on the glycosylation profile of a monoclonal antibody,” Springer Plus, Jan. 28, 2013, 2(25):1-10.
[cited by applicant]
Danielson et al., “Maximizing cell densities in miniprep-scale cultures with H15 medium and improved oxygen transfer,” Biochemical Engineering J, Mar. 2004, 17:175-180.
[cited by applicant]
De Jesus et al., “Tubespin satellites, A fast track approach for process development with animal cells using shaking technology,” Biotechnology and Bioengineering Journal, Mar. 2004, 17:217-223.
[cited by applicant]
Domansky et al., “Perfused multiwell plate for 3D liver tissue engineering,” Lab on a Chip, Jan. 1, 2010, 10(1):51-58.
[cited by applicant]
Duvar et al., “Developing an upstream process for a monoclonal antibody including medium optimization,” BMC Proceedings, Jun. 2013, 7(Suppl. 6):34.
[cited by applicant]
Ecker et al., “Mammalian cell culture capacity for biopharmaceutical manufacturing,” Adv. Bicochem. Eng. Biotechnol., Jun. 2013, 139:185-225.
[cited by applicant]
Environmental Protection Agency, “Integrated Pollution Prevention and Control Licensing,” Application Form, Office of Licensing & Guidance, Jan. 20, 2006, 81 pages.
[cited by applicant]
Environmental Protection Agency, “Integrated Pollution Prevention and Control Licensing,” Proof of Publication, Office of Licensing & Guidance, Jan. 20, 2006, 2 pages.
[cited by applicant]
Enzyscreen, Cultivation of CHO cells in microplates, Webpage, May 3, 2014.
[cited by applicant]
Eriksson et al., “The manufacturing process for B-domain deleted Recombinant Factor VIII,” Seminars in Hematology, Apr. 2001, 38(2):24-31, Suppl. 4.
[cited by applicant]
European Opposition in Patent Application No. 15730933.7, dated Aug. 19, 2020, 2020, 29 pages.
[cited by applicant]
European Opposition in Patent Application No. 15730933.7, dated Aug. 25, 2020, 35 pages.
[cited by applicant]
European Opposition in Patent Application No. 15730933.7, dated Aug. 26, 2020, 94 pages.
[cited by applicant]
Examination Report in Singapore Patent Application No. 11201503085V, dated Dec. 12, 2018, 7 pages.
[cited by applicant]
Examination Report in Singapore Patent Application No. 11201503085V, dated Dec. 7, 2016, 9 pages.
[cited by applicant]
Examination Report in Singapore Patent Application No. 11201503085V, dated Feb. 17, 2018, 7 pages.
[cited by applicant]
Examination Report in Singapore Patent Application No. 11201503085V, dated Nov. 21, 2016, 9 pages.
[cited by applicant]
Examination Report in Singapore Patent Application No. 11201506339R, dated Jul. 13, 2017, 7 pages.
[cited by applicant]
Examination Report in Singapore Patent Application No. 11201506339R, dated Jul. 21, 2016.
[cited by applicant]
Examination Report in Singapore Patent Application No. 11201506339R, dated May 2, 2018, 7 pages.
[cited by applicant]
Examination Report in Singapore Patent Application No. 11201506343Q, dated Jul. 13, 2017, 5 pages.
[cited by applicant]
Examination Report in Singapore Patent Application No. 11201506343Q, dated Jun. 27, 2016, 5 pages.
[cited by applicant]
Examination Report in Singapore Patent Application No. 1120160167W, dated Oct. 17, 2017, 7 pages.
[cited by applicant]
Examination Report in Singapore Patent Application No. 11201610216U, dated Oct. 11, 2017, 6 pages.
[cited by applicant]
Extended European Search Report in Application No. 18205923.8, dated Jan. 14, 2019, 9 pages.
[cited by applicant]
Extended European Search Report in Application No. 20188132.3, dated Oct. 1, 2020, 9 pages.
[cited by applicant]
Extended European Search Report in Patent Application No. 21161811.1, dated Jun. 21, 2021, 11 pages.
[cited by applicant]
Fenge et al., “Cell Culture Bioreactors”, Cell Culture Technology for Pharmaceutical and Cell-Based Therapies, 2006, Chapter 6.
[cited by applicant]
Fernandes-Platzgummer et al., “Scale-up of mouse embryonic stem cell expansion in stirred bioreactors,” American Institute Chemical Engineers, Sep./Oct. 2011, 27(5):1421-1432.
[cited by applicant]
GB-1ml, Greiner Bio 96 Well Masterblock 1ml, Catalog Webpage, 2020, 3 pages.
[cited by applicant]
GB-2ml, Greiner Bio 96 Well Masterblock 2ml, Catalog Webpage, 2020, 4 pages.
[cited by applicant]
GE Healthcare Life Sciences, “Highly efficient inoculum propagation in perfusion culture using Wave Bioreactor system”, Application Note, 2012.
[cited by applicant]
Gebauer et al., “Engineered protein scaffolds as next-generation antibody therapeutics,” Curr. Opin. Chem. Biol., Epub Jun. 6, 2009, 13(3): 245-255.
[cited by applicant]
Genzel et al., “High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells”, Vaccine, May 19, 2014, 32(24):2770-2781.
[cited by applicant]
Gorfien et al., “Recombinant Protein Production by CHO Cells Cultured in a Chemically Defined Medium,” Animal Cell Technology: Basic & Applied Aspects, 1998, pp. 247-252.
[cited by applicant]
Griffiths et al., “Mammalian Cell Culture Reactors, Scale-Up”, Encyclopedia of Bioprocess Technology: Fermentation, Biocatalysis, and Bioseparation, 1999, pp. 1594-1607.
[cited by applicant]
Gupta et al., “Optimization of agitation speed in spinner flask for microcarrier structural integrity and expansion of induced pluripotent stem cells,” Cytotechnology, 2014, 15 pages.
[cited by applicant]
Hecht et al., “Efficiency improvement of an antibody production process by increasing the inoculum density,” Biotechnol. Prag., Feb. 2014, 30(3):607-615.
[cited by applicant]
Heidemann et al., “A new seed-train expansion method for recombinant mammalian cell lines,” Cytotechnology, 2002, vol. 38, pp. 99-108.
[cited by applicant]
Henry et al., “Simpler Noninstrumented Batch and Semicontinuous Cultures Provide Mammalian Cell Kinetic Data Comparable to Continuous and Perfusion Cultures,” Biotechnology Progress, Jul. 2008, 24(4):921-931.
[cited by applicant]
Huang et al., “Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment,” American Institute of Chemical Engineers Biotechnol. Prog., Sep.…
[cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/US2013/066410, dated May 7, 2015, 8 pages.
[cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/US2014/017785, dated Sep. 3, 2015, 8 pages.
[cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/US2014/017803, dated Aug. 25, 2015, 8 pages.
[cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/US2015/034494, dated Dec. 6, 2016, 14 pages.
[cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/US2013/066410, dated Jan. 31, 2014, 12 pages.
[cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/US2014/017785, dated May 20, 2014, 11 pages.
[cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/US2014/017803, dated May 20, 2014, 11 pages.
[cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/US2015/034494, dated Nov. 30, 2015, 24 pages.
[cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/US2015/034709, dated Oct. 30, 2015, 13 pages.
[cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/US2015/067040, dated Sep. 5, 2016, 19 pages.
[cited by applicant]
Invitation to Pay in International Application PCT/US2015/034494, dated Aug. 12, 2015, 6 pages.
[cited by applicant]
Jayapal et al., “Recombinant Protein Therapeutics from CHO cells—20 years and counting,” Chemical Engineering Progress, Oct. 2007, 103(10): 40-47.
[cited by applicant]
Kaisermayer et al., “Highly efficient inoculum propagation in perfusion culture using Wave BioreactorTM systems,” BMC Proceedings, Dec. 2013, 7(Suppl 6):P7.
[cited by applicant]
Kantardjieff et al., “Mammalian cell cultures for biologics manufacturing,” Mammalian Cell Cultures for Biologics Manufacturing, 2013, 18 pages.
[cited by applicant]
Katakam et al., “Effect of Surfactants on the physical stability of recombinant human growth hormone,” Journal of Pharmaceutical Association, Jun. 1, 1995, 84(6):713-716.
[cited by applicant]
Kim et al., “Batch, Fed-Batch and Microcarrier Cultures with CHO cell lines in a pressure-cycle driven miniturized bioreactor,” Biotechnology and Bioengineering, Oct. 2011, 109(1):137-145.
[cited by applicant]
Kirti et al., “Comparison of the behavior of CHO cells during cultivation in 24-square deep well microplates and conventional shake flask systems,” Biotechnology Reports, Jun. 2014, 1-2:22-26.
[cited by applicant]
Klockner et al., “Advances in shaking technologies,” Trends in Biotechnology, Jun. 2012, 30(6):307-314.
[cited by applicant]
Kloth et al., “Inoculum Expansion Methods, Recombinant Mammalian Cell Lines,” Encyclopedia of Industrial Biotechnology: Bioprocess, Bioseparation, and Cell Technology, 2010, pp. 2988-3000.
[cited by applicant]
Kompala et al., “Optimization of high cell density perfusion bioreactors,” Cell Culture Technology for Pharmaceutical and Cell-Based Therapies, 2006, Chapter 11.
[cited by applicant]
Konstantinov, “Developing an integrated Continuous Bioprocessing Platform,” BioProcess Int., Dec. 1, 2012, 6 pages.
[cited by applicant]
Kshirsagar et al., “Controlling Trisulfide Modification in Recombinant Monoclonal Antibody Produced in Fed-Batch Cell Culture,” Biotechnology and Bioengineering, 2012, 109(10): 2523-2532.
[cited by applicant]
Langer, “Trends in perfusion bioreactors—The next revolution in bioprocessing?” BioProcess International, Nov. 2011, 9(10):18-22.
[cited by applicant]
Liu et al., “Application and development trend of bioreactor animal cell culture technology in the biological field,” Biotechnology World, Jun. 15, 2013, vol. 6, p. 8 (with Machine Translation).
[cited by applicant]
Loffelholz et al., “Dynamic single-use bioreactors used in modern liter and m3-scale biotechnological processes: Engineering characteristics and scaling up,” Adv. Biochem. Eng. Biotechnol., Apr. 2013, 138:1-44.
[cited by applicant]
Mackay-Scollay, “A simple quantitative and qualitative microbiological screening test for bacteriuria,” J. Clin. Path., 1969, pp. 651-653.
[cited by applicant]
Morozov et al, “Development of continuous cultivation of CHO cells producing recombinant blood coagulation factor VIII,” Biopreparats (Biopharmaceuticals), 2015, pp. 26-31.
[cited by applicant]
Nam et al., “The effects of microcarrier culture on recombinant CHO cells under biphasic hypothermic culture conditions,” Cytotechnology, May 2, 2009, 59(2):81-91.
[cited by applicant]
Nelson, “Facility Design”, Cell Culture Technology for Pharmaceutical and Cell-Based Therapies, 2006, Chapter 16, 51 pages.
[cited by applicant]
New Webster's Dictionary, “Dispose”, 1975, pp. 452-453.
[cited by applicant]
Notice of Allowance in Australian Patent Application No. 2015274897, dated Oct. 20, 2021, 3 pages.
[cited by applicant]
Notice of Allowance in Korean Patent Appln. No. 10-2017-7000249, dated Mar. 29, 2022, 2 pages (with English translation).
[cited by applicant]
Office Action in Australian Patent Application No. 201334602, dated May 23, 2017, 2 pages.
[cited by applicant]
Office Action in Australian Patent Application No. 2014218715, dated Mar. 15, 2019, 6 pages.
[cited by applicant]
Office Action in Australian Patent Application No. 2014218715, dated Nov. 27, 2019, 3 pages.
[cited by applicant]
Office Action in Australian Patent Application No. 2014218723, dated Mar. 15, 2019, 3 pages.
[cited by applicant]
Office Action in Australian Patent Application No. 2015269184, dated Mar. 29, 2021, 3 pages.
[cited by applicant]
Office Action in Australian Patent Application No. 2015274897, dated May 17, 2021, 3 pages.
[cited by applicant]
Office Action in Australian Patent Application No. 2015274897, dated Oct. 9, 2020, 5 pages.
[cited by applicant]
Office Action in Australian Patent Application No. 201569184, dated Aug. 12, 2020, 6 pages.
[cited by applicant]
Office Action in Australian Patent Application No. 2018222985, dated May 22, 2020, 7 pages.
[cited by applicant]
Office Action in Australian Patent Application No. 2021245116, dated Nov. 7, 2022, 3 pages.
[cited by applicant]
Office Action in Brazilian Application No. BR112016028891-2, dated Dec. 3, 2019, 5 pages.
[cited by applicant]
Office Action in Brazilian Application No. BR122023000469-8, dated Mar. 21, 2023, 7 pages (with English translation).
[cited by applicant]
Office Action in Brazilian Patent Application No. BR112016028512-3, dated Aug. 11, 2021, 11 pages (with English translation).
[cited by applicant]
Office Action in Brazilian Patent Application No. BR112016028512-3, dated Nov. 12, 2019, 9 pages.
[cited by applicant]
Office Action in Brazilian Patent Application No. BR112016028891-2, dated Oct. 11, 2022, 7 pages (with English translation).
[cited by applicant]
Office Action in Brazilian Patent Application No. BR122023000469-8, dated Jul. 20, 2023, 10 pages (with English translation).
[cited by applicant]
Office Action in Canadian Patent Application No. 2,889,022, dated Dec. 30, 2020, 3 pages.
[cited by applicant]
Office Action in Canadian Patent Application No. 2,889,022, dated Oct. 24, 2019, 5 pages.
[cited by applicant]
Office Action in Canadian Patent Application No. 2,901,940 dated Mar. 29, 2021, 21 pages.
[cited by applicant]
Office Action in Canadian Patent Application No. 2,901,940, dated Dec. 12, 2019, 4 pages.
[cited by applicant]
Office Action in Canadian Patent Application No. 2,901,950, dated Feb. 17, 2021, 3 pages.
[cited by applicant]
Office Action in Canadian Patent Application No. 2,951,255, dated Jun. 7, 2021, 4 pages.
[cited by applicant]
Office Action in Canadian Patent Application No. 2,951,551, dated Jun. 9, 2021, 4 pages.
[cited by applicant]
Office Action in Canadian Patent Application No. 2901950, dated Dec. 4, 2019, 3 pages.
[cited by applicant]
Office Action in Chinese Chinese Patent Application No. 201810153403.8, dated Nov. 4, 2020, 18 pages.
[cited by applicant]
Office Action in Chinese Patent Application No. 201380067513.8, dated Apr. 13, 2016, 23 pages.
[cited by applicant]
Office Action in Chinese Patent Application No. 201380067513.8, dated Dec. 29, 2016, 22 pages.
[cited by applicant]
Office Action in Chinese Patent Application No. 201380067513.8, dated Jun. 6, 2017, 15 pages.
[cited by applicant]
Office Action in Chinese Patent Application No. 201480022715.5, dated Aug. 31, 2018, 69 pages.
[cited by applicant]
Office Action in Chinese Patent Application No. 201480022715.5, dated Feb. 13, 2018, 59 pages.
[cited by applicant]
Office Action in Chinese Patent Application No. 201480022715.5, dated Jan. 6, 2021, 109 pages.
[cited by applicant]
Office Action in Chinese Patent Application No. 201480022715.5, dated Jul. 21, 2020, 44 pages.
[cited by applicant]
Office Action in Chinese Patent Application No. 201480022715.5, dated Jul. 5, 2017, 16 pages (62 pages including English Translation).
[cited by applicant]
Office Action in Chinese Patent Application No. 201480022715.5, dated May 15, 2017, 78 pages.
[cited by applicant]
Office Action in Chinese Patent Application No. 201480022766.8, dated Jan. 3, 2018, 7 pages.
[cited by applicant]
Office Action in Chinese Patent Application No. 201480022766.8, dated Jan. 9, 2019, 23 pages.
[cited by applicant]
Office Action in Chinese Patent Application No. 201480022766.8, dated Jun. 5, 2019, 28 pages.
[cited by applicant]
Office Action in Chinese Patent Application No. 201480022766.8, dated May 4, 2017, 14 pages.
[cited by applicant]
Office Action in Chinese Patent Application No. 201580042017.6, dated Jan. 8, 2021, 23 pages (with English translation).
[cited by applicant]
Office Action in Chinese Patent Application No. 201580042017.6, dated Jun. 12, 2020, 17 pages.
[cited by applicant]
Office Action in Chinese Patent Application No. 201580042488.7, dated Feb. 7, 2020, 8 pages.
[cited by applicant]
Office Action in Chinese Patent Application No. 201580042488.7. dated Feb. 11, 2019, 2 pages.
[cited by applicant]
Office Action in Chinese Patent Application No. 201580042488.7. dated Oct. 8, 2019, 7 pages.
[cited by applicant]
Office Action in Chinese Patent Application No. 202010299662.9, dated Dec. 21, 2022, 22 pages (with English translation).
[cited by applicant]
Office Action in European Patent Application No. 19209942.2, dated Mar. 18, 2021, 3 pages.
[cited by applicant]
Office Action in European Patent Application No. 15731177.0, dated Jul. 12, 2018, 5 pages.
[cited by applicant]
Office Action in European Patent Application No. 15731177.0, dated Jul. 27, 2023, 4 pages.
[cited by applicant]
Office Action in European Patent Application No. 15731177.0, dated Oct. 14, 2021, 5 pages.
[cited by applicant]
Office Action in European Patent Application No. 19209942.2, dated Jan. 14, 2020, 10 pages.
[cited by applicant]
Office Action in European Patent Application No. 19209942.2, dated May 8, 2023, 3 pages.
[cited by applicant]
Office Action in European Patent Application No. 21161811.1, dated Nov. 29, 2023, 4 pages.
[cited by applicant]
Office Action in Indian Patent Application No. 1291/KOLNP/2015, dated Jun. 27, 2018, 13 pages.
[cited by applicant]
Office Action in Indian Patent Application No. 201737000132, dated Jul. 11, 2023, 4 pages.
[cited by applicant]
Office Action in Indian Patent Application No. 201737000132, dated May 13, 2021, 6 pages.
[cited by applicant]
Office Action in Indian Patent Application No. 201737000152, dated Jul. 14, 2021, 7 pages.
[cited by applicant]
Office Action in Indian Patent Application No. 201737000152, dated May 14, 2020, 11 pages.
[cited by applicant]
Office Action in Indian Patent Application No. 2762/KOLNP/2015, dated Jan. 15, 2020, 11 pages.
[cited by applicant]
Office Action in Indian Patent Application No. 2763/KOLNP/2015, dated May 15, 2020, 11 pages.
[cited by applicant]
Office Action in Israel Patent Application No. 249384, dated Dec. 8, 2019, 4 pages (English Translation Only).
[cited by applicant]
Office Action in Israel Patent Application No. 249384, dated Feb. 14, 2021, 9 pages (with English translation).
[cited by applicant]
Office Action in Israel Patent Application No. 249452, dated Dec. 1, 2019, 8 pages.
[cited by applicant]
Office Action in Israel Patent Application No. 249452, dated Nov. 15, 2018, 7 pages.
[cited by applicant]
Office Action in Israel Patent Application No. 253071, dated Dec. 17, 2019, 4 pages.
[cited by applicant]
Office Action in Israel Patent Application No. 290096, dated Aug. 28, 2022, 4 pages (English translation only).
[cited by applicant]
Office Action in Japanese Application No. 2022-092635, dated May 30, 2023, 5 pages (with English translation).
[cited by applicant]
Office Action in Japanese Patent Application No. 2016-571259, dated Apr. 16, 2019, 6 pages.
[cited by applicant]
Office Action in Japanese Patent Application No. 2016-571259, dated Jan. 28, 2020, 9 pages.
[cited by applicant]
Office Action in Japanese Patent Application No. 2016-571259, dated Oct. 6, 2020, 8 pages.
[cited by applicant]
Office Action in Japanese Patent Application No. 2016-572251, dated Jan. 7, 2020, 5 pages.
[cited by applicant]
Office Action in Japanese Patent Application No. 2020-177043 dated Oct. 19, 2021, 8 pages (with English translation).
[cited by applicant]
Office Action in Japanese Patent Application No. 2021-116795 dated Aug. 30, 2022, 12 pages (with English translation).
[cited by applicant]
Office Action in Japanese Patent Application No. 2021-116795, dated Feb. 28, 2023, 7 pages (with English translation).
[cited by applicant]
Office Action in Korean Appln. No. 10-2017-7000144, dated May 30, 2022, 4 pages (with English translation).
[cited by applicant]
Office Action in Korean Patent Application No. 10-2017-7000144, dated Nov. 20, 2021, 8 pages (with English translation).
[cited by applicant]
Office Action in Korean Patent Application No. 10-2017-7000249, dated Oct. 13, 2021, 21 pages (with English translation).
[cited by applicant]
Office Action in Korean Patent Application No. 10-2022-7022305, dated Apr. 26, 2023, 5 pages (with English translation).
[cited by applicant]
Office Action in Korean Patent Application No. 10-2022-7022305, dated Oct. 19, 2022, 16 pages (with English translation).
[cited by applicant]
Office Action in Korean Patent Application No. 10-2022-7044019, dated Jul. 19, 2023, 4 pages (with English translation).
[cited by applicant]
Office Action in Mexican Application No. MX/a/2016/016142, dated Dec. 14, 2020, 10 pages.
[cited by applicant]
Office Action in Mexican Patent Application No. MX/a/2015/005206, dated Aug. 24, 2018, 6 pages.
[cited by applicant]
Office Action in Mexican Patent Application No. MX/a/2015/005206, dated May 28, 2018, 6 pages.
[cited by applicant]
Office Action in Mexican Patent Application No. MX/a/2015/010941, dated Feb. 1, 2019, 9 pages.
[cited by applicant]
Office Action in Mexican Patent Application No. MX/a/2015/010941, dated Nov. 20, 2018, 6 pages.
[cited by applicant]
Office Action in Mexican Patent Application No. MX/a/2015/010943, dated Jun. 4, 2019, 9 pages.
[cited by applicant]
Office Action in Mexican Patent Application No. MX/a/2016/016142, dated Jun. 2, 2021, 8 pages (with English translation).
[cited by applicant]
Office Action in Mexican Patent Application No. MX/a/2016/016142, dated Mar. 11, 2020, 11 pages.
[cited by applicant]
Office Action in Mexican Patent Application No. MX/a/2016/016301, dated Feb. 17, 2020, 6 pages.
[cited by applicant]
Office Action in Mexican Patent Application No. MX/a/2016/016301, dated Oct. 30, 2018.
[cited by applicant]
Office Action in Mexican Patent Application No. MX/a/2019/003638, dated Jul. 27, 2020, 9 pages (with English Translation).
[cited by applicant]
Office Action in Mexican Patent Application No. MX/a/2019/003638, dated Mar. 9, 2021, 6 pages (with English translation).
[cited by applicant]
Office Action in Mexican Patent Application No. MX/a/2019/009189, dated Jul. 27, 2020, 7 pages (with English Translation).
[cited by applicant]
Office Action in Mexican Patent Application No. MX/a/2019/013310, dated Mar. 24, 2021, 10 pages (with English translation).
[cited by applicant]
Office Action in Mexican Patent Application No. MX/a/2020/004073, dated Apr. 26, 2024, 24 pages (with English translation).
[cited by applicant]
Office Action in Mexican Patent Application No. MX/a/2020/009670, dated May 9, 2024, 14 pages (with English translation).
[cited by applicant]
Office Action in Russian Application No. 2016151316, dated May 14, 2019, 8 pages.
[cited by applicant]
Office Action in Russian Patent Application No. 2016151316, dated Nov. 15, 2018, 19 pages.
[cited by applicant]
Office Action in Russian Patent Application No. 2016152238, dated Feb. 13, 2019, 10 pages.
[cited by applicant]
Office Action in Russian Patent Application No. 2016152238, dated May 30, 2019, 6 pages.
[cited by applicant]
Office Action in Russian Patent Application No. 2016152238, dated Oct. 1, 2019, 14 pages.
[cited by applicant]
Office Action in Russian Patent Application No. 2019138327, dated Apr. 1, 2020, 15 pages.
[cited by applicant]
Office Action in Russian Patent Application No. 2019138327, dated Jul. 22, 2020, 13 pages.
[cited by applicant]
Office Action in Russian Patent Application No. 2020131199, dated Apr. 6, 2021, 15 pages (with English translation).
[cited by applicant]
Office Action in Singapore Patent Application No. 11201610216U, dated Sep. 6, 2022, 6 pages.
[cited by applicant]
Office Action in Taiwanese Patent Application No. 104118071, dated Mar. 11, 2021, 13 pages (with English translation).
[cited by applicant]
Office Action in Taiwanese Patent Application No. 104118071, dated Mar. 3, 2020, 12 pages.
[cited by applicant]
Office Action in Taiwanese Patent Application No. 104118071, dated Sep. 30, 2020, 15 pages.
[cited by applicant]
Office Action in Taiwanese Patent Application No. 104118240, dated Feb. 17, 2020, 1 page.
[cited by applicant]
Office Action in Taiwanese Patent Application No. 109131864, dated Sep. 29, 2021, 8 pages (with English translation).
[cited by applicant]
Office Action in U.S. Appl. No. 16/799,592, mailed on Apr. 23, 2024, 11 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 16/799,592, mailed on Sep. 20, 2023, 19 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 17/358,889, dated Oct. 5, 2023, 8 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/061,657 on Nov. 24, 2017, 9 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/061,657 on Nov. 5, 2015, 12 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/061,657, dated Aug. 19, 2016, 14 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/061,657, dated Jun. 18, 2018, 10 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/061,657, dated May 4, 2020, 23 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/732,325, dated Dec. 4, 2019, 13 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/732,325, dated Jun. 15, 2020, 17 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/732,325, dated May 16, 2018, 12 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/733,630, dated Feb. 21, 2018, 6 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/733,630, dated Feb. 7, 2019, 8 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/733,630, dated May 11, 2017, 14 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/733,630, on Nov. 15, 2016, 13 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/769,772, dated Dec. 6, 2016, 19 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/769,772, dated May 9, 2017, 23 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/769,783 dated Oct. 1, 2018, 32 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/769,783, dated Feb. 22, 2018, 19 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/769,783, dated Mar. 28, 2017, 38 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/769,783, dated Nov. 3, 2016, 31 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/769,783, dated Oct. 10, 2017, 23 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 15/874,645, dated Jul. 1, 2019, 7 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 16/799,592, dated Aug. 18, 2022, 16 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 16/799,592, dated Mar. 16, 2023, 18 pages.
[cited by applicant]
Office Action in U.S. Appl. No. 14/732,325, dated Sep. 20, 2017, 10 pages.
[cited by applicant]
Ohashi et al., “Perfusion cell culture in disposable bioreactors,” Animal Cell Technology: From Target to Market, 2001, pp. 403-409.
[cited by applicant]
Ongena et al., “Determining Cell Number During Cell Culture using the Scepter Cell Counter,” Jove, 2010, 45(e2204): 1-5.
[cited by applicant]
Oosterhuis et al., “Single-use bioreactors for microbial cultivation,” Pharmaceutical Bioprocessing, 2013, 1(2):167-177.
[cited by applicant]
Opposition, “Response to Communication by Michiels”, Exhibit D18 in European Application No. 15730933.7, Apr. 11, 2019, 6 pages.
[cited by applicant]
Ozturk, “Equipment for large-scale mammalian cell culture,” Adv. Biochem. Eng. Biotechnol., Sep. 5, 2013, 139:69-92.
[cited by applicant]
Ozturk, “Equipment for large-scale mammalian cell culture,” Confirmation about date of publication, Advances in Biochemical Engineering/Biotechnology, Jan. 1, 2014, 2 pages.
[cited by applicant]
Padawer et al., “Case Study: an accelerated 8-day monoclonal antibody production process based on high seeding densities,” Biotechnol Prog., 2013, 29(3): 829-832.
[cited by applicant]
Pohlscheidt et al., “Optimizing capacity utilization by large scale 3 000 L perfusion in seed train bioreactors,” Biotech. Prog., Jan. 1, 2012, 29(1):222-229.
[cited by applicant]
Pollock et al., “Fed-batch and perfusion culture processes: Economic, environmental, and operational feasibility under uncertainty,” Biotechnology and Bioengineering, Jan. 2013, 110(1):206-219.
[cited by applicant]
Qi Yizheng et al., “Oxygen transfer reaction characteristics,” Chemical Industry Press, Bioreaction Engineering, dated Jul. 31, 2004, pp. 134-139.
[cited by applicant]
Quinlan et al., “A semicontinuous culture model that links cell growth to extracellular nutrient concentration,” Biotechnology and Bioengineering, 1986, XXVII:1455-1461.
[cited by applicant]
Raja et al., “Challenges in scaling up a perfusion process,” BMC Proceedings, 2011, vol. 5, Supplement 8, p. P122.
[cited by applicant]
Rodrigues et al., “Technological progresses in monoclonal antibody production systems,” Biotechnology Progress, Mar.-Apr. 2010, 26(2):332-351.
[cited by applicant]
Schirmer et al., “Primary clarification of very high density cell culture harvests by enhanced cell settling,” BioProcress International, Jan. 2010, pp. 32-39.
[cited by applicant]
Scott, “Growth of mesenchymal stromal cells in automated microwell cultures: influence of the engineering environment on cell growth kinetics and non-directed differentiation,” (Doctoral dissertation, UCL (University Co…
[cited by applicant]
Senger et al., “Effect of shear stress on intrinsic CHO culture state and glycosylation of recombinant tissue-type plasminogen activator protein,” Biotechnology Progress, Jul.-Aug. 2003, 19(4): 1199-1209.
[cited by applicant]
Seth et al., “Development of a New Bioprocess Scheme Using Frozen Seed Train Intermediates to Initiate CHO Cell Culture Manufacturing Campaigns,” Biotechnology and Bioengineering, 2012, 110(5): 1376-1385.
[cited by applicant]
Shevitz et al., “An Economic Comparison of Three Cell Culture Techniques,” BioPharm International, Feb. 1, 2011, 24(2).
[cited by applicant]
Shi et al., “Expansion of Mouse Sertoli Cells on Microcarriers,” Cell Proliferation, Jun. 2010, 43(3):275-286.
[cited by applicant]
Shi et al., “Growth and Metabolism of Hybridoma Cells in Semicontinuous Perfusion Cultures,” Chinese Journal of Biotechnology, Jan. 23, 2000, 16(1):51-54 (with English abstract).
[cited by applicant]
Shukla et al., “Single-use disposable technologies for biopharmaceutical manufacturing,” Trends in Biotechnology, Mar. 2013, 31(3): 147-154.
[cited by applicant]
sigmaaldrich.com [online], “Corning-24, Corning costar ultra-low attachment mutiwell plate,” Sep. 2013, Retrieved on Jan. 10, 2018, retrieved from: URL<https://www.sigmaaldrich.com/catalog/product/sigma/cls3473?lang=en&…
[cited by applicant]
Silk et al., “Fed-batch operation of an industrial cell culture process in shaken microwells,” Biotechnol Lett., Jan. 2010, Epub Sep. 17, 2009, 32(1):73-78.
[cited by applicant]
Smelko et al., “Performance of high intensity fed-batch mammalian cell cultures in disposable bioreactor systems,” Biotechnology Progress, Sep. 2011, 27(5):1358-1364.
[cited by applicant]
Soyer et al., “Introducing shear stress in the study of bacterial adhesion,” J. Vis. Exp., Sep. 2011, (55):e3241.
[cited by applicant]
Strnad et al., “Optimization of cultivation conditions in spin tubes for Chinese hamster ovary cells producing erythropoietin and the comparison of glycosylation patterns in different cultivation vessels,” Biotechnology…
[cited by applicant]
Su, “Bioreactors, perfusion”, Encyclopedia of Industrial Biotechnology: Bioprocess, Bioseparation, and Cell Technology, 2009, pp. 1-16.
[cited by applicant]
Tang et al., “Perfusion Culture of Hybridoma Cells for Hyperproduction of IgG2a Monoclonal Antibody in a Wave Bioreactor-Perfusion Culture System,” 2007, vol. 23, pp. 255-264.
[cited by applicant]
Tao et al., “Development and implementation of a perfusion-based high cell density cell banking process,” Biotechnology Progress, May-Jun. 2011, 27(3):824-829.
[cited by applicant]
Technical specification of Vi-Cell XR Cell Viability Analyzer, 2010.
[cited by applicant]